Bloodwork question about DSIP. Baseline, four months in, and the numbers moved in a direction I did not expect.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
Injection site reactions are trivial until they are not, and a fresh needling technique removes half of them.
Willing to accept that my own experience is the weakest evidence in the room.
Test one thing at a time. It feels slower and it is the only way to learn anything.
Nobody has ever been talked out of a stack by a stranger on the internet. Four months in on DSIP and it lines up.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Narrow conclusion.